The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Serum hyaluronate in primary biliary cirrhosis–a biochemical marker for progressive liver damage
Abstract
To evaluate serum hyaluronate as a marker for progressive liver injury in patients with primary biliary cirrhosis, a longitudinal study including 48 patients was conducted with a mean follow-up time of 40 months. The patients were examined every 6 months with a standardized set of conventional liver function tests, and a liver biopsy was performed every year. The hyaluronate concentration correlated significantly (p < 0.001) with albumin, t 1/2 galactose tolerance test, bilirubin and prothrombin time but not to serum variables reflecting inflammatory activity. Furthermore, there was a close correlation between serum hyaluronate levels and histopathological changes in the liver. The hyaluronate concentration increased significantly over time in all clinical stages of primary biliary cirrhosis (p < 0.01), whereas the conventional liver function tests only changed in the advanced cases. The present data indicate that serum hyaluronate may be a sensitive marker for progressive liver damage in primary biliary cirrhosis. Serial determinations of hyaluronate are therefore of potential value for monitoring liver function during clinical management of the condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyaluronic acid was the first marker to show significant association with clinical outcomes [81,82].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [81]
In the citing paper
“Hyaluronic acid was the first marker to show significant association with clinical outcomes [81,82].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [81]
Citations
Cites
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417
Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells
Smedsrød, B., Pertoft, H., Eriksson, S., Fraser, J. R. E., & Laurent, T. C. (1984) · Biochemical Journal · doi:10.1042/bj2230617 · Cited by 297
Increased Serum Levels of Hyaluronate in Liver Disease
Engström-Laurent, A., Lööf, L., Nyberg, A., & Schröder, T. (1985) · Hepatology · doi:10.1002/hep.1840050420 · Cited by 243
Self-citationConcentration of sodium hyaluronate in serum
Engström-Laurent, A., Laurent, U. B. G., Lilja, K., & Laurent, T. C. (1985) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518509155249 · Cited by 228
Engström-Laurent, A., & Hällgren, R. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.2.83 · Cited by 204
ELIMINATION OF HYALURONIC ACID FROM THE BLOOD STREAM IN THE HUMAN
Fraser, J. R. E., Laurent, T. C., Engström‐Laurent, A., & Laurent, U. G. B. (1984) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1984.tb00235.x · Cited by 192
Asymptomatic primary biliary cirrhosis
Beswick, D. R., Klatskin, G., & Boyer, J. L. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90325-7 · Cited by 148
Engström‐Laurent, A., & Hällgren, R. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301203 · Cited by 141
Beswick, D. R., Klatskin, G., & Boyer, J. L. (1985) · PubMed · Cited by 117
Research works printed but not linked: 4
- James, 1981, Lancet, 1, 1278
- Scheuer, 1967, Proc R Soc Med, 60, 1257
- Fraser, 1986, J Lab Clin Med, 107, 79
- Sherlock, 1982, Scand J Gastroenterol, 17, 63
Cited by
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Noninvasive diagnosis of hepatic fibrosis or cirrhosis
Oberti, F., Valsesia, E., Pilette, C., Rousselet, M., Bedossa, P., Aube, C., Gallois, Y., Rifflet, H., Maiga, M., Penneau-Fontbonne, D., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352863 · Cited by 375
McHutchison, J. G., Blatt, L. M., De Medina, M., Craig, J. R., Conrad, A., Schiff, E. R., Tong, M. J., & Group, T. C. I. S. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02233.x · Cited by 229
Pilette, C., Rousselet, M. C., Bedossa, P., Chappard, D., Oberti, F., Rifflet, H., Maïga, M. Y., Gallois, Y., & Calès, P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80318-8 · Cited by 205
Serum Hyaluronan as a Disease Marker
Laurent, T. C., Laurent, U. B. G., & Fraser, J. R. E. (1996) · Annals of Medicine · doi:10.3109/07853899609033126 · Cited by 175
Metadata
- Authors
- Nyberg, A., Engström-Làurent, A., & Lööf, L.
- Affiliations
- Uppsala University Hospital (SE)
- Corresponding author
- Nyberg, Anders
- ORCID
- Nyberg, Anders
- Venue
- Hepatology
- Published
- 1988-01
- Volume
- 8
- Issue
- 1
- Pages
- 142-146
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2073402254
- Semantic Scholar
- b93d1eecf8d27c66ec88414c008cc1e9651e67a5
- Cited by
- 134
- References
- 18
- Citations by year
- 2025: 1 · 2023: 1 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 4 · 2012: 1
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 10105 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- primary biliary cirrhosis, biochemical markers, liver function monitoring, liver histopathology, liver biopsy, serum albumin, prothrombin time, bilirubin, galactose tolerance test
- MeSH terms
- Biopsy, Female, Follow-Up Studies, Humans, Hyaluronic Acid, Liver, Liver Cirrhosis, Biliary, Liver Function Tests, Longitudinal Studies, Male, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum hyaluronate in primary biliary cirrhosis–a biochemical marker for progressive liver damage. https://app.cochat.ai/papers/10.1002/hep.1840080127
- The paper
- Nyberg, A., Engström-Làurent, A., & Lööf, L. (1988). Serum hyaluronate in primary biliary cirrhosis–a biochemical marker for progressive liver damage. Hepatology. https://doi.org/10.1002/hep.1840080127
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.